Etudes Non Stop Study Non Stop
Related Articles
The Cystinosis Research Foundation works closely with the CRF Scientific Review Board (SRB) comprised of leading experts in the field of cystinosis who determine the scientific validity and merit of the grant proposals based on the NIH scale of standards. The SRB advises the Cystinosis Research Foundation on the scientific merit of each proposal.
CRF Announces the 2022 Spring Call for Cystinosis Research Grant and Fellowship Applications
The ultimate goal of the Cystinosis Research Foundation is to find better treatments and a cure for cystinosis. Global calls for grant applications are made twice each year, in the spring and the fall. To be considered, research and fellowship applications must take into consideration the mission and goals of the foundation. The research and fellowship grants are awarded for 1-2 years.
Currently, the Cystinosis Research Foundation has $2.5 million available for research and fellowship grants. The number of awards and their value will depend on the number of outstanding proposals and the funds available at the time.
The deadline for submittal of the Spring 2022 Grant Proposals and Fellowship Applications is Friday, April 15, 2022. The successful grant applicants will be notified by the end of June 2022. Please note that the earliest start date for research projects submitted for this cycle is September 1, 2022.
For Grant Awardees
CRF required reporting forms after receiving a grant:
Progress reports are required at regular intervals for the duration of the study and a final report is required at the study’s conclusion. These progress reports should be an executive overview of the study’s progress against key milestones and should include any personnel updates. The progress reports must also include a budget report which shall be a one-page detailed accounting of budget receipts and expenditures. Grant payments will be linked to these reports.
Download:
Researcher Email Sign-Up
Sign up to be alerted of new Research and Fellowship Grant opportunities. Contact us.
